18 July 2023>: Clinical Research
Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospective Study
Yunfeng Zhang ABCE , Jiayang J. Sun BCD , Zhuo Zhang BCD , Fei Huang CDF , Jiayin Lv CDF , Qingsan Zhu AG*DOI: 10.12659/MSM.940134
Med Sci Monit 2023; 29:e940134
Table 1 Univariable analysis of the Control group and NVCF group.
Variable | Overall (n=279) | Control group (n=232) | NVCF group (n=47) | P |
---|---|---|---|---|
Age (years) | 71.11±8.84 | 70.60±8.59 | 73.64±9.70 | 0.033* |
Gender (n, %) | 0.866 | |||
Female | 228 (81.7) | 190 (81.9) | 38 (80.9) | |
Male | 51 (18.3) | 42 (18.1) | 9 (19.1) | |
BMI (kg/m) | 22.77±3.17 | 23.04±3.16 | 21.43±2.92 | 0.002* |
Hypertension (n, %) | 0.115 | |||
No | 167 (59.9) | 134 (57.8) | 33 (70.2) | |
Yes | 112 (40.1) | 98 (42.2) | 14 (29.8) | |
Diabetes (n, %) | 0.511 | |||
No | 228 (81.7) | 188 (81.0) | 40 (85.1) | |
Yes | 51 (18.3) | 44 (19.0) | 7 (14.9) | |
History of smoking (n, %) | 0.270 | |||
No | 245 (87.8) | 206 (88.8) | 39 (83.0) | |
Yes | 34 (12.2) | 26 (11.2) | 8 (17.0) | |
History of alcohol (n, %) | 0.745 | |||
No | 258 (92.5) | 214 (92.2) | 44 (93.6) | |
Yes | 21 (7.5) | 18 (7.8) | 3 (6.4) | |
Fracture level (n, %) | 0.090 | |||
Non-TL junction | 73 (26.2) | 56 (24.1) | 17 (36.2) | |
TL junction | 206 (73.8) | 176 (75.9) | 30 (63.8) | |
Surgical method (n, %) | 0.853 | |||
PVP | 199 (71.3) | 166 (71.6) | 33 (70.2) | |
PKP | 80 (28.7) | 66 (28.4) | 14 (29.8) | |
Bone cement leakage (n, %) | 0.733 | |||
No | 190 (68.1) | 157 (67.7) | 33 (70.2) | |
Yes | 89 (31.9) | 75 (32.3) | 14 (29.8) | |
Bone cement volume (ml) | 4.51±0.81 | 4.50±0.82 | 4.55±0.75 | 0.699 |
HU value | 72.23±26.98 | 77.69±24.63 | 45.27±21.45 | 0.000* |
AVHR | 0.72±0.13 | 0.71±0.13 | 0.75±0.14 | 0.070 |
NVCF – new vertebral compression fracture; BMI – body mass index; TL – thoracolumbar; PVP – percutaneous vertebroplasty; PKP – percutaneous kyphoplasty; HU – Hounsfield unit; AVHR – anterior vertebral height ratio. * P |